Drug Enforcement Administration
Skip Navigation

Press Room
News Releases
E-mail updates red envelope
Speeches & Testimony
Multi-Media Library

About Us
Mission
Leadership
History
Organizational Chart
Programs & Operations
Wall of Honor
DEA Museum
Office Locations

Careers at DEA

Drug Information

Law Enforcement
Most Wanted
Major Operations
Threat Assessment
Training Programs
Stats & Facts
Additional Resources

Drug Prevention
For Young Adults
Additional Resources

Diversion Control & Prescription Drugs
Registration
Cases Against Doctors

Drug Policy
Controlled Substances Act
Federal Trafficking Penalties
Drug Scheduling

Legislative Resources

Publications

Acquisitions & Contracts

News Release [print friendly page]
For Immediate Release:
May 7, 2008

Contact: Douglas S. Collier
Public Information Officer
(973) 776-1143 (Office)
(862) 849-9833 (Cell)

Pharmaceutical Diversion Investigative Training Seminar

June 10, 2008 – June 12, 2008
Rutgers University, Cook Campus
59 Biel Road
New Brunswick, NJ

Presented by:
Drug Enforcement Administration (DEA)
In Cooperation with:
Middlesex County Prosecutor’s Office
Rutgers University Police Department

DEA
NEW JERSEY DIVISION

The Drug Enforcement Administration New Jersey Division will be conducting a three day seminar on Pharmaceutical Diversion Investigations. This training program is designed to prepare the police officer and other law enforcement officials to recognize specialized problems and contemporary issues associated with the diversion of pharmaceutical controlled substances and federally regulated Chemicals. Topics which will be covered will include DEA Diversion Program, Internet Pharmaceutical Diversion, Emerging Trends in Pharmaceutical use and abuse, Undercover Issues, and Methods of Diversion.

The objective of this course is to enable the law enforcement personnel the ability to recognize and identify the current methods of diversion and to determine and implement the investigative process that can be used for overall prosecutorial success.

*Abuse of controlled prescriptions drugs is a major problem in the United States. According to a July, 2005 report from The National Center on Addiction and Substance Abuse (CASA) at Columbia University, the number of Americans who abuse controlled prescription drugs nearly doubled from 1992 to 2003 and abuse among teens more than tripled during that same time period. Americans abusing controlled prescription drugs exceed the number abusing cocaine, heroin, hallucinogens and inhalants, combined.

For more information and registration, please contact the DEA New Jersey Division's Timothy McMahon at (973) 776-7067.

 

 

Home USDOJ.GOV Privacy Policy Contact Us Site Map